当前位置:主页 > 医学论文 > 药学论文 >

乙酸巴多昔芬合成路线图解

发布时间:2018-06-04 16:56

  本文选题:巴多 + 乙酸盐 ; 参考:《中国医药工业杂志》2017年02期


【摘要】:正乙酸巴多昔芬(bazedoxifene acetate,1),化学名1-[4-[2-(环己亚胺基-1-基)乙氧基]苄基]-2-(4-羟基苯基)-3-甲基-1H-吲哚-5-酚乙酸盐,是Wyeth公司研制的第三代选择性雌激素受体调节药,于2009年4月首次在欧洲上市,主要用于治疗女性绝经后的骨质疏松症。与同类药物相比,1疗效更好、安全性更高,具有广阔的市场前景~([1])。
[Abstract]:Bazedoxifene acetate, chemical name 1- [4- [2-( cyclohexylamino-1-yl) ethoxy] benzyl] -2-oxy 4-hydroxyphenyl -3-methyl-1H-indole -5-phenolic acetate, is the third generation selective estrogen receptor regulator developed by Wyeth Company, and its chemical name is 1- [4- [2-( cyclohexylaminyl-1-yl) ethoxy] benzyl] -2-oxy-4-hydroxyphenyl -3-methyl-1H-indole -5-phenolic acetate, which is the third generation of selective estrogen receptor regulator developed by Wyeth. First launched in Europe in April 2009, mainly for treatment of postmenopausal osteoporosis in women. Compared with the similar drugs, it has better efficacy and higher safety, and has a broad market prospect ([1]).
【作者单位】: 南京工业大学;扬子江药业集团有限公司;
【分类号】:R914.5

【相似文献】

相关期刊论文 前2条

1 陈维;帮助害羞的他们[J];健康生活;1998年07期

2 ;[J];;年期



本文编号:1978118

资料下载
论文发表

本文链接:https://www.wllwen.com/yixuelunwen/yiyaoxuelunwen/1978118.html


Copyright(c)文论论文网All Rights Reserved | 网站地图 |

版权申明:资料由用户b0ec3***提供,本站仅收录摘要或目录,作者需要删除请E-mail邮箱bigeng88@qq.com